NDC 75987-150-03
UPLIZNA 10 mg/mL
Inebilizumab · INJECTION
UPLIZNA is a injection containing inebilizumab at a strength of 10 mg/mL. Manufactured by Horizon Therapeutics USA, Inc..
Key Facts
- Brand Name
- UPLIZNA
- Generic Name
- Inebilizumab
- NDC Code (Package)
75987-150-03- NDC Code (Product)
75987-150- Manufacturer
- Horizon Therapeutics USA, Inc.
- Strength
- 10 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761142
- Drug Class
- CD19-directed Cytolytic Antibody [EPC]
- Marketing Start
- 06/11/2020
Recall History
No Recall HistoryView Full Drug Page
UPLIZNA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.